Scarica l'app Stockscreener
257.92
0.58%
1.50
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RMD Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Resmed Inc Borsa (RMD) Ultime notizie
What analysts say about ResMed Inc. stockFree Capital Growth Strategies - Jammu Links News
Is ResMed Inc. a good long term investmentExplosive portfolio gains - Jammu Links News
ResMed Inc. Stock Analysis and ForecastAccelerated wealth building - Jammu Links News
This ResMed Insider Reduced Their Stake By 72% - simplywall.st
This Pick Withstood the GLP-1 Challenge. Stick With the Stock. - Barron's
Analyst Expectations For ResMed's Future - Nasdaq
ResMed (RMD) Price Target Increased to $270 by Mizuho Analyst | - GuruFocus
Brokers Set Expectations for ResMed's Q1 Earnings (NYSE:RMD) - MarketBeat
RBC Upgrades ResMed to Outperform From Sector Perform, Adjusts Price Target to $294 From $255 - MarketScreener
ResMed's Trading Volume Surges 78.7% to 2.35 Billion, Stock Price Drops 0.11% Placing 406th in Market Rankings - AInvest
ResMed (NYSE:RMD) Seems To Use Debt Rather Sparingly - 富途牛牛
ResMed CEO Executes Stock Transactions Under Rule 10b5-1 Plan - TipRanks
Resmed CEO Farrell sells $2.06 million in stock By Investing.com - Investing.com Canada
Resmed Insider Sold Shares Worth $2,056,076, According to a Recent SEC Filing - MarketScreener
ResMed Inc. Officer Plans Sale of Common Stock Under Rule 144 - TipRanks
With 75% institutional ownership, ResMed Inc. (NYSE:RMD) is a favorite amongst the big guns - simplywall.st
ResMed CFO Reports Changes in Stock Ownership - TipRanks
ResMed to Release Q4 2025 Financial Results on July 31, 2025, via Webcast - AInvest
ResMed Executives Sell Shares Under Pre-arranged Trading Plans - TradingView
ResMed: Why Insider Sales Under 10b5-1 Plans Don't Dampen Long-Term Appeal - AInvest
ResMed Chief Legal Officer Sells Shares - MarketScreener
Resmed Inc Officer Files Notice for Stock Sale Under Rule 144 - TipRanks
Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025 | RMD Stock News - GuruFocus
Resmed Announces Fourth Quarter Fiscal Year 2025 Financial Results Release and Webcast Details - Nasdaq
ResMed (NYSE:RMD) Shows Growth in ROCE and Business Efficiency NYSE Composite - Kalkine Media
Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025 - Morningstar
Zacks.com featured highlights Sprouts Farmers Market, Adobe, GE Aerospace and ResMed - Yahoo Finance
All You Need to Know About ResMed (RMD) Rating Upgrade to Buy - Yahoo Finance
Is the ResMed share price still cheap? What the numbers say - The Motley Fool Australia
ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Bi Level Automatic Ventilator Market Is Booming Worldwide 2025-2032 | ResMed Inc., Philips Healthcare, Medtronic Plc - openPR.com
ResMed Stock: Is RMD Outperforming the Healthcare Sector? - MSN
ResMed Inc. (RMD) Investor Outlook: Analyzing Growth Potential Amidst a 6% Upside - DirectorsTalk Interviews
ResMed Stock: Is RMD Outperforming The Healthcare Sector? - Barchart.com
Resmed CEO Michael Farrell sells shares worth $2.01 million By Investing.com - Investing.com South Africa
ResMed: A Mixed Bag for Investors Amid Rising Competition - The Globe and Mail
Resmed CEO Michael Farrell sells shares worth $2.01 million - Investing.com
ResMed CEO Sells Shares Worth $2 Million - MarketScreener
ResMed Inc Reports Change in Beneficial Ownership - TipRanks
ResMed: A Sleeping Giant Hiding In Plain Sight (NYSE:RMD) - Seeking Alpha
Up more than 75% since October 2023 — are ResMed shares a buy, hold or sell? - MSN
Insider Sell: Peter Farrell Sells 2,000 Shares of ResMed Inc (RMD) - GuruFocus
ResMed director Peter Farrell sells $494,640 in stock By Investing.com - Investing.com Nigeria
ResMed director Peter Farrell sells $494,640 in stock - Investing.com Australia
ResMed Inc Director Proposes Sale of Common Shares - TipRanks
Successful Exits - University College Dublin
ResMed (RMD) is a Top-Ranked Growth Stock: Should You Buy? - Yahoo Finance
Insider Sell: Brett Sandercock Sells 1,000 Shares of ResMed Inc (RMD) - GuruFocus
ResMed CFO Sells Shares - marketscreener.com
Resmed Inc Reports Decrease in CDI Issuance for May 2025 - TipRanks
ResMed CFO Executes Stock Sale Under Rule 10b5-1 Plan - TipRanks
ResMed Inc. Officer Files Notice for Proposed Sale of Securities - TipRanks
ResMed’s global general counsel Michael Rider sells $9,994 in shares By Investing.com - Investing.com Nigeria
0.45%
1.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):